about
sameAs
Comparative analysis of the treatment of chronic antipsychotic drugs on epileptic susceptibility in genetically epilepsy-prone rats.Central serotonin-2A (5-HT2A) receptor dysfunction in depression and epilepsy: the missing link?Psychogenic polydipsia: the result, or cause of, deteriorating psychotic symptoms? A case report of the consequences of water intoxicationTrifluoperazine-induced angioedemaWorld Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, part 1: update 2012 on the acute treatment of schizophrenia and the management of treatment resistance.Perampanel and challenging behaviour in intellectual disability and epilepsy: a management dilemma.The development and testing of the quality use of medications in dementia (QUM-D): a tool for quality prescribing for behavioral and psychological symptoms of dementia (BPSD).Tolerability, Safety, and Benefits of Risperidone in Children and Adolescents with Autism: 21-Month Follow-up After 8-Week Placebo-Controlled Trial.A review of clozapine safety.Pharmaco-EEG in psychiatry.Late-onset seizures associated with quetiapine poisoningIncidence of new-onset seizures in mild to moderate Alzheimer diseaseHow Prolific is Psychotropic Medicines Use in People with Dementia in Australia Within the Community Setting? A Retrospective Analysis.Lithium therapy in comorbid temporal lobe epilepsy and cycloid psychosis.Toxicology today: what you need to know now.Role of haloperidol in palliative medicine: an update.The role of different serotonin receptor subtypes in seizure susceptibility.Management of nausea and vomiting in palliative care.Multidisciplinary assessment and treatment of self-injurious behavior in autism spectrum disorder and intellectual disability: integration of psychological and biological theory and approach.Mania secondary to focal brain lesions: implications for understanding the functional neuroanatomy of bipolar disorder.Antipsychotic drug use and the risk of seizures: follow-up study with a nested case-control analysis.Effects of concurrent perioperative use of marbofloxacin and cimicoxib or carprofen in dogs.Medication-induced acute dystonic reaction: the challenge of diagnosing movement disorders in the intensive care unitEffects of Psychotropic Drugs on Seizure Threshold during Electroconvulsive Therapy.[Polypharmacy and pain treatment].G-protein gene 825C>T polymorphism is associated with response to clozapine in Brazilian schizophrenics.Aripiprazole-induced seizure.Plasma concentrations of risperidone and olanzapine during coadministration with oxcarbazepine.Buspirone for autistic disorder in a woman with an intellectual disability.Analogy between psychosis antedating epilepsy and epilepsy antedating psychosis.Narcolepsy in Adolescence-A Missed Diagnosis: A Case Report.Olanzapine: review of safety 2008
P2860
Q27339093-DF416260-AEDD-4FBA-A017-0FA728D84FA5Q28080944-64D91D72-3F4A-45A4-82BB-DC0408875C44Q28257158-7B11824A-6E9B-4E5C-8219-4FFC774C355DQ34114393-839ECA7C-5E0E-404B-A21B-F1E1107975F7Q34640811-6C67EB37-CC76-4D14-AEED-37A136CCB4FAQ34793587-6AD1F993-1691-47A4-99DF-CD72A15DCBCDQ35848943-0DCA2F95-A4DE-4B5E-8945-A6D74E0684EEQ35985482-EFB5D804-6FFA-4DF9-9B34-E98CC4A36DABQ36191044-5E7AF7FA-36FD-45D9-B9C2-BFD18AD98988Q36492216-CF114DE5-2CC5-4DBB-8149-034AE81E4FEDQ36549245-DE399586-3ED6-42BD-82C4-9EBBA15DB105Q36754121-B876191F-EE3F-40BE-AC1C-84C27E8DDFE5Q36942933-F683F1B0-F586-479A-8924-69D983374C12Q37532500-C3F962C7-106D-4A60-B5AC-728CFDC47FE2Q37895391-BCB1FA2B-2658-4EF0-BE50-01753EE3B752Q37945595-9F2CB774-D52B-41DC-883D-D3EFB38CC14BQ38162732-B372B8E8-33C0-44DA-8D5D-06BE66176692Q38231509-9ACA9A26-FFEC-4E65-9FE6-446A08010992Q38268023-0E87E2C5-A2F0-44B9-A3F7-4E0D293A3F33Q38816915-31FB170E-E662-437E-9DB3-74E53C74FB1BQ40660915-6F5EC991-B916-42C4-9383-CA07A2843F04Q40826392-C3E0B96E-6629-4DF6-A5DE-8A56AF4AA6B0Q41705048-F49A2F22-EA91-419B-91AA-03D3DCCD461FQ42376213-05346898-356F-41CF-B4BD-8378008C3460Q42966263-93852F6E-92CE-4FB5-8203-6A6F907C6A63Q46316258-0F90533D-0DE7-4C86-87BA-24B6270DACA8Q46438053-1F36DA41-01D0-46F5-A639-713136E70BD2Q46460408-7F15C4B6-9C59-4CAC-B29C-2D18BCAC2FACQ46868346-09346D29-62AE-47E2-8240-1F050D20DCDCQ51806614-B718161A-B60D-4C09-BCBF-D5B6ED855871Q54996426-771BDD52-3A38-45D8-A448-A06591FADBB9Q56791028-55997449-2714-4477-AAC6-811DB36E833C
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Antipsychotic medication and seizures: a review
@ast
Antipsychotic medication and seizures: a review
@en
Antipsychotic medication and seizures: a review
@nl
type
label
Antipsychotic medication and seizures: a review
@ast
Antipsychotic medication and seizures: a review
@en
Antipsychotic medication and seizures: a review
@nl
prefLabel
Antipsychotic medication and seizures: a review
@ast
Antipsychotic medication and seizures: a review
@en
Antipsychotic medication and seizures: a review
@nl
P2093
P1433
P1476
Antipsychotic medication and seizures: a review
@en
P2093
Dawson Hedges
Kreg Jeppson
Paul Whitehead
P356
10.1358/DOT.2003.39.7.799445
P407
P577
2003-07-01T00:00:00Z